ASMA AHMED: Open Payments
NPI 1407990146 · WEST ROXBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 59 payments from 12 companies in 2025. Trend: 2023 $1,413 · 2024 $8,164 · 2025 $1,192
Food & beverage: $1,064Education: $127
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $210 |
| Janssen Pharmaceuticals, Inc | 8 | $203 |
| Teva Pharmaceuticals USA, Inc. | 6 | $160 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Alkermes, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $48 |
Products named: FANAPT, REXULTI, AUSTEDO XR, SPRAVATO, COBENFY, INVEGA SUSTENNA, Sunosi, INGREZZA.
Industry payments across MA — which companies pay providers there.
